期刊文献+

造影剂肾病临床研究概况 被引量:3

原文传递
导出
摘要 一、造影剂肾病的定义造影剂肾病也称造影剂肾损害或造影剂所致急性肾损伤,其定义临床上并不完全统一,但最常使用的临床定义为使用造影剂后48 h内出现血肌酐上升超过其基础值的25%或超过0.5 mg/dl(44 μmol/L),且能除外造影外的其他原因.
作者 杨定位
出处 《中华临床医师杂志(电子版)》 CAS 2012年第19期5982-5985,共4页 Chinese Journal of Clinicians(Electronic Edition)
基金 天津医科大学科研基金(2004ky31)
  • 相关文献

参考文献19

  • 1Gussenhoven MJ;Ravensbergen J;van Bockel JH.Renal dysfunction after angiography:a risk factor analysis in patients with peripheral vascular disease,1991.
  • 2Hou SH;Bushinsky DA;Wish JB.Hospital-acquired renal insufficiency:a prospective study,1983.
  • 3McCullough PA;Wolyn R;Rocher LL.Acute renal failure after coronary intervention:Incidence,risk factors,and relationship to mortality,1997.
  • 4杨定位,贾汝汉,杨定平,丁国华,黄从新.Dietary hypercholesterolemia aggravates contrast media-induced nephropathy[J].Chinese Medical Journal,2004(4):542-546. 被引量:3
  • 5Vogt B;Ferrari P;Schonholzer C.Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful,2001.
  • 6Parfrey PS;Griffiths SM;Barrett BJ.Contrast material-induced renal failure in patients with diabetes mellitus,renal insufficiency,or both.A prospective controlled study,1989.
  • 7Neumayer HH;Junge W;Kufner A.Prevention of radiocontrastmedia-induced nephrotoxicity by the calcium channel blocker nitrendipine:a prospective randomised clinical trial,1989.
  • 8Heyman SN;Rosen S;Rosenberger C.Renal parenchymal hypoxia,hypoxia adaptation and the pathogenesis of radiocontrast nephropathy,2008.
  • 9Nash K;Hafeez A;Hou S.Hospital-acquired renal insufficiency,2002.
  • 10Solomon R;Werner C;Mann D.Effects of saline,mannitol,and furosemide on acute decreases in renal function induced by radiocontrast agents,1994.

二级参考文献50

  • 1汪斌,刘志忠,张丰富.冠状动脉介入诊治中高敏C反应蛋白与造影剂肾病的相关性分析[J].中国医药,2007,2(8):457-459. 被引量:35
  • 2Thomsen HS.Guidelines for contrast media from the European Soeiety of Urogenital Radioloy. American Journal of Roentgenology . 2003
  • 3Isenbarger DW,Kent SM,O‘Malley PG, et al.Meta analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy. The American Journal of Cardiology . 2003
  • 4Cavusoglu E,Chhabra S,Marmur JD,et al.The prevention of con-trast-induced nephropathy in patients undergoing percutaneous coro-nary intervention. Minerva Cardioangiologica . 2004
  • 5Tepel M,Zidek W.Acetylcysteine and contrast media nephropathy. Current Opinion in Nephrology and Hypertension . 2002
  • 6Birck R,Krzossok S,Markowetz F,et al.Acetylcysteine for prevention of contrast nephropathy: meta-analysis. The Lancet . 2003
  • 7Nash K,Hafeez A,Hou S,et al.Hospital-acquired renal insufficiency. American Journal of Kidney Diseases . 2002
  • 8Kay J,Chow WH,Chan TM,et al.Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. Journal of the American Medical Association, The . 2003
  • 9Alonso A,Lau J,Jaber BL,et al.Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. American Journal of Kidney Diseases . 2004
  • 10Briguori C,Airoldi F,D’Andrea D,et al.Renal insufficiencyfollowing contrastmedia administration trial(REMEDIAL):arandomized comparison of 3 preventive strategies. Circulation . 2007

共引文献38

同被引文献26

  • 1邓海红,来青,周小娟.数字减影全脑血管造影及介入治疗术后并发症的观察及护理[J].实用神经疾病杂志,2005,8(6):89-90. 被引量:25
  • 2Lopez AD,Murray CC.The global burden of disease:1990-2020[J].Nat Med,1998,4(11):1 241.
  • 3Widimsky P,Bilkova D,Penicka M,et al.Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention.Five years’follow-up of the PRAGUE-2 Trial[J].Eur Heart J,2007,28(6):679.
  • 4Solomon R,Dauerman HL.Contrast-induced acute kidney injury[J].Circulation,2010,122(23):2 451.
  • 5Stacul F,van der Molen AJ,Reimer P,et al.Contrast induced nephropathy:updated ESUR Contrast Media Safety Committee guidelines[J].Eur Radiol,2011,21(12):2 527.
  • 6Persson PB,Hansell P,Liss P.Pathophysiology of contrast medium-induced nephropathy[J].Kidney Int,2005,68(1):14.
  • 7Fleming I,Kohlstedt K,Busse R.New FACEs to the renin-angiotensin system[J].Physiology:Bethesda,2005,20:91.
  • 8Toprak O,Cirit M,Bayata S,et al.The effect of pre-procedural captopril on contrast-induced nephropathy in patients who underwent coronary angiography[J].Anadolu Kardiyol Derg,2003,3(2):98.
  • 9Umruddin Z,Moe K,Superdock K.ACE inhibitor or angiotensinⅡreceptor blocker use is a risk factor for contrast-induced nephropathy[J].J Nephrol,2012,25(5):776.
  • 10Stacul F,van der Molen AJ,Reimer P,et al.Contrast induced nephropathy:updated ESUR Contrast Media Safety Committee guidelines[J].Eur Radiol,2011,21(12):2527.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部